MEDINCELL. Trademark

Trademark Overview


On Thursday, October 17, 2024, a trademark application was filed for MEDINCELL. with the United States Patent and Trademark Office. The USPTO has given the MEDINCELL. trademark a serial number of 79413864. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, April 6, 2026. This trademark is owned by MedinCell S.A.. The MEDINCELL. trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific apparatus and instruments, namely, tools for injecting and administering liquid formulations into testing equipment or other drug delivery devices; laboratory apparatus and instruments for extracting excipients or active pharmaceutical ingredients from in situ forming depots, not for medical purposes; apparatus and instruments for chemical analysis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis; apparatus and instruments for measuring, testing and analysing chemical compositions; apparatus for analysing gases; weighing apparatus and instruments; measuring apparatus and instruments, namely, flow controllers; recorded or downloadable computer software for the quantitative long-term monitoring of the release pharmaceutical ingredients into a patient's body; computer hardware

Laboratory research, testing and research laboratory analysis services in the field of drug delivery; laboratory services, namely, medical research laboratories; chemical analysis; medical, scientific and industrial research in the field of long-acting injectable compositions and providing information relating thereto; pharmaceutical drug development services; pharmaceutical research and development services; rental of laboratory apparatus and instruments; design and development of laboratory and diagnostic apparatus; development and testing of algorithms and software; consultancy in the field of pharmaceutical research and development; services for assessing the efficiency of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals, chemical analysis and clinical trials; providing scientific research information; scientific research in the fields of medicine, pharmacology and veterinary medicine

Pharmaceutical preparations and substances for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, and for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical compositions for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, disea...
medincell.

General Information


Serial Number79413864
Word MarkMEDINCELL.
Filing DateThursday, October 17, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, April 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 28, 2026

Trademark Statements


Goods and ServicesScientific apparatus and instruments, namely, tools for injecting and administering liquid formulations into testing equipment or other drug delivery devices; laboratory apparatus and instruments for extracting excipients or active pharmaceutical ingredients from in situ forming depots, not for medical purposes; apparatus and instruments for chemical analysis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis; apparatus and instruments for measuring, testing and analysing chemical compositions; apparatus for analysing gases; weighing apparatus and instruments; measuring apparatus and instruments, namely, flow controllers; recorded or downloadable computer software for the quantitative long-term monitoring of the release pharmaceutical ingredients into a patient's body; computer hardware
Goods and ServicesLaboratory research, testing and research laboratory analysis services in the field of drug delivery; laboratory services, namely, medical research laboratories; chemical analysis; medical, scientific and industrial research in the field of long-acting injectable compositions and providing information relating thereto; pharmaceutical drug development services; pharmaceutical research and development services; rental of laboratory apparatus and instruments; design and development of laboratory and diagnostic apparatus; development and testing of algorithms and software; consultancy in the field of pharmaceutical research and development; services for assessing the efficiency of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals, chemical analysis and clinical trials; providing scientific research information; scientific research in the fields of medicine, pharmacology and veterinary medicine
Goods and ServicesPharmaceutical preparations and substances for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, and for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical compositions for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; carriers for pharmaceutical and veterinary preparations being drug delivery agents in the form of dissolvable films, and coatings for tablets that facilitate the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; bacteriological culture or cell culture mediums for pharmaceutical and veterinary preparations being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary preparations and substances for subcutaneous delivery for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedinCell S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 2, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 5, 2025APPLICATION FILING RECEIPT MAILED
Saturday, September 6, 2025ASSIGNED TO EXAMINER
Wednesday, September 10, 2025NON-FINAL ACTION WRITTEN
Thursday, September 11, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 2, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 29, 2025REFUSAL PROCESSED BY MPU
Wednesday, October 29, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 15, 2025REFUSAL PROCESSED BY IB
Friday, March 27, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 27, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 28, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 8, 2026NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 8, 2026NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 22, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 23, 2026NOTIFICATION PROCESSED BY IB